Bio-sight Capital - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $112,519.69 -1.68%
Ethereum $3,984.35 -3.75%
BNB $1,104.40 -3.60%
Optimism $0.44 -3.89%
Arbitrum $0.32 -5.08%
Solana $194.34 -3.52%
Polygon $0.22 +2.77%
Cosmos $3.09 -2.68%
Avalanche $19.44 -4.90%

Bitcoin $112,519.69 -1.68%
Ethereum $3,984.35 -3.75%
BNB $1,104.40 -3.60%
Optimism $0.44 -3.89%
Arbitrum $0.32 -5.08%
Solana $194.34 -3.52%
Polygon $0.22 +2.77%
Cosmos $3.09 -2.68%
Avalanche $19.44 -4.90%

Bio-sight Capital

investment firm

Summary
Investments
Exits

About

Bio-sight Capital is a private investment firm focused on lab business and investment business.

Ibaraki,Osaka,Japan
http://www.bs-capital.co.jp

Highlights

Lead Investments

Details

Founded date: Jan 1, 2002
Operating Status: Active
Legal Name: Bio-sight Capital, Inc.
Also Known As: バイオ・サイト・キャピタル,Bio-Sight Capital Co., Ltd.
Investor Type: Venture Capital

Bio-sight Capital is a private investment firm focused on lab business and investment business.

Investments

Number of Investments

Number of Lead Investments

6

1

Bio-sight Capital has made 6 investments. Their most recent investment was on Aug 14, 2020, when FunPep raised ¥1.50B.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Aug 14, 2020 FunPep	Series Unknown	¥1.50B	Medical Device	—
Oct 5, 2018 FunPep	Series Unknown	¥460M	Medical Device	—
Dec 18, 2015 JTEC CORPORATION Japan	Series Unknown	¥148.48M	Manufacturing	—
Apr 10, 2015 FunPep	Series Unknown	¥25.60M	Medical Device	—
Jun 11, 2008 Gene Techno Science	Series Unknown	¥500.25M	Biopharma	—

Show More

Exits

Bio-sight Capital has had 2 exits. Bio-sight Capital most notable exits include JTEC CORPORATION Japan , Gene Techno Science

Date	Company Name	Exit Type	Industry
Feb 28, 2018	JTEC CORPORATION Japan	IPO	Manufacturing	Detail
Nov 30, 2012	Gene Techno Science	M&A	Biopharma	Detail